Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant

Overview of attention for article published in Blood, November 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,961 followers.

RT @mumairmushtaq: Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access ... https://t.co/dCieMk5LQU

Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access ... https://t.co/dCieMk5LQU

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.